Home
/
Xenetic Biosciences, Inc.
/
Financials
/
Quarterly
Xenetic Biosciences, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Xenetic Biosciences, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.03M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$589.9K
Aug 12, 2025
Q1
2025
Mar 31, 2025
$593.3K
May 13, 2025
Q3
2025
Sep 30, 2024
$614.2K
Nov 12, 2025
Q2
2025
Jun 30, 2024
$726.4K
Aug 12, 2025
Q1
2025
Mar 31, 2024
$510.8K
May 13, 2025
Q3
2024
Sep 30, 2023
$611.2K
Nov 12, 2024
Q2
2024
Jun 30, 2023
$651.0K
Aug 13, 2024
Q1
2024
Mar 31, 2023
$605.8K
May 9, 2024
Q3
2023
Sep 30, 2022
$414.3K
Nov 9, 2023
Q2
2023
Jun 30, 2022
$416.7K
Aug 10, 2023
Q1
2023
Mar 31, 2022
$389.0K
May 11, 2023
Q3
2022
Sep 30, 2021
$349.3K
Nov 9, 2022
Q2
2022
Jun 30, 2021
$287.6K
Aug 11, 2022
Q1
2022
Mar 31, 2021
$191.2K
May 12, 2022
Q3
2021
Sep 30, 2020
$115.9K
Nov 12, 2021
Q2
2021
Jun 30, 2020
$112.9K
Aug 12, 2021
Q1
2021
Mar 31, 2020
$56.7K
May 11, 2021
Q3
2020
Sep 30, 2019
$0
Nov 12, 2020
Q2
2020
Jun 30, 2019
$0
Aug 12, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($509.9K)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($688.7K)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($903.1K)
May 13, 2025
Q3
2025
Sep 30, 2024
($436.7K)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($1.27M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($1.20M)
May 13, 2025
Q3
2024
Sep 30, 2023
($1.06M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.05M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($856.6K)
May 9, 2024
Q3
2023
Sep 30, 2022
($804.0K)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($2.67M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($1.59M)
May 11, 2023
Q3
2022
Sep 30, 2021
($1.35M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($1.11M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($1.35M)
May 12, 2022
Q3
2021
Sep 30, 2020
($7.56M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($953.6K)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($1.18M)
May 11, 2021
Q3
2020
Sep 30, 2019
($8.90M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($1.38M)
Aug 12, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($544.7K)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($724.4K)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($942.4K)
May 13, 2025
Q3
2025
Sep 30, 2024
($499.5K)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($1.34M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($1.27M)
May 13, 2025
Q3
2024
Sep 30, 2023
($1.15M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.20M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($915.2K)
May 9, 2024
Q3
2023
Sep 30, 2022
($847.8K)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($2.69M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($1.62M)
May 11, 2023
Q3
2022
Sep 30, 2021
($1.38M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($1.13M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($1.37M)
May 12, 2022
Q3
2021
Sep 30, 2020
($10.50M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($982.5K)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($1.23M)
May 11, 2021
Q3
2020
Sep 30, 2019
($8.95M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($1.38M)
Aug 12, 2020